BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 682532)

  • 1. Enhancement of mechanisms acting against mammary carcinoma: pancreatic trypsin inhibitor.
    Hakim AA
    Klin Wochenschr; 1978 Aug; 56(15):767-77. PubMed ID: 682532
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulation of DNA synthesis in human fibroblasts by human pancreatic secretory trypsin inhibitor.
    Ogawa M; Tsushima T; Ohba Y; Ogawa N; Tanaka S; Ishida M; Mori T
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):155-8. PubMed ID: 3909270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of human and ovine pancreatic secretory trypsin inhibitors on the proliferation of normal human fibroblasts.
    Hamilton I; Reynolds GW; Scott GK; Sharfe N; Tse CA
    Biol Chem Hoppe Seyler; 1990 Jan; 371(1):79-83. PubMed ID: 2322422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function relationship for Kunitz and Kazal type trypsin inhibitors.
    Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Antonini E
    Farmaco Sci; 1983 Dec; 38(12):978-97. PubMed ID: 6365586
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes.
    Marks WH; Eddeland A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Covalent immobilization of the pancreatic trypsin inhibitor on a polymeric carrier].
    Maklakova IA; Valueva TA; Kolosova GV; Valuev LI; Mosolov VV
    Prikl Biokhim Mikrobiol; 1983; 19(5):654-8. PubMed ID: 6417650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypsin activation. Effect of the Ile-Val dipeptide concentration on Kazal inhibitor binding to bovine trypsinogen.
    Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
    Biochim Biophys Acta; 1985 Dec; 832(3):378-82. PubMed ID: 4074755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Soluble high molecular weight derivatives of pancreatic trypsin inhibitor. Modification of pancreatic trypsin inhibitor by soluble polysaccharides activated by titanium tetrachloride].
    Larionova NI; Kazanskaia NF; Sakharov IIu; Mitiushina GV
    Biokhimiia; 1980 Apr; 45(4):683-6. PubMed ID: 7378496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaction of a tumour-associated trypsin inhibitor with serine proteinases associated with coagulation and tumour invasion.
    Turpeinen U; Koivunen E; Stenman UH
    Biochem J; 1988 Sep; 254(3):911-4. PubMed ID: 2461702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of atropine on rat pancreatic secretory response to trypsin inhibitors and protein.
    Levan VH; Green GM
    Am J Physiol; 1986 Jul; 251(1 Pt 1):G64-9. PubMed ID: 3728678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-lactalbumin production in human mammary carcinoma.
    Rose HN; McGrath CM
    Science; 1975 Nov; 190(4215):673-5. PubMed ID: 1188362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition spectra of the human pancreatic endopeptidases.
    Mallory PA; Travis J
    Am J Clin Nutr; 1975 Aug; 28(8):823-30. PubMed ID: 1080008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein inhibitors of proteinases.
    Laskowski M; Kato I
    Annu Rev Biochem; 1980; 49():593-626. PubMed ID: 6996568
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancreatic secretory trypsin inhibitor stimulates the growth of rat pancreatic carcinoma cells.
    Freeman TC; Curry BJ; Calam J; Woodburn JR
    Gastroenterology; 1990 Nov; 99(5):1414-20. PubMed ID: 2210248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and complete amino acid sequence of canine pancreatic secretory trypsin inhibitor.
    Kikuchi N; Nagata K; Yoshida N; Tanaka T; Yamamoto M; Saitoh Y
    FEBS Lett; 1985 Oct; 191(2):269-72. PubMed ID: 4054311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-Lactalbumin in human and subhuman primate normal mammary tissue and in human breast cancer as a marker for prolactin activity.
    Kleinberg DL; Todd J
    Cancer Res; 1978 Nov; 38(11 Pt 2):4318-22. PubMed ID: 100218
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of prolactin on lactalbumin production by normal and malignant human breast tissue in organ culture.
    Wilson GD; Woods KL; Walker RA; Howell A
    Cancer Res; 1980 Feb; 40(2):486-9. PubMed ID: 6243254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luminal CCK-releasing factors in the isolated vascularly perfused rat duodenojejunum.
    Cuber JC; Bernard G; Fushiki T; Bernard C; Yamanishi R; Sugimoto E; Chayvialle JA
    Am J Physiol; 1990 Aug; 259(2 Pt 1):G191-7. PubMed ID: 2382718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to epidermal growth factors of cultured human mammary epithelial cells from benign tumours.
    Stoker MG; Pigott D; Taylor-Papadimitriou J
    Nature; 1976 Dec 23-30; 264(5588):764-7. PubMed ID: 1012318
    [No Abstract]   [Full Text] [Related]  

  • 20. Secretion of pancreatic secretory trypsin inhibitor by cultured human carcinoma cells.
    Ogawa M; Yamaguchi N; Chung SM; Shiroeda O; Shibata T; Mori T
    J Med; 1988; 19(1):13-9. PubMed ID: 3221140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.